Klotho neurosciences, inc.KLTOW.US Overview

US StockHealthcare

(No presentation for KLTOW)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock SentimentalTradingView Chart

KLTOW Overall Performance

KLTOW AI Analysis & Strategy

KLTOW Recent Performance

Klotho neurosciences, inc.

0.81%

Avg of Sector

-1.14%

S&P500

KLTOW PowerScanner

KLTOW Key Information

KLTOW Valuation Metrics

KLTOW Earnings Table

KLTOW Profile

Klotho Neurosciences, Inc., a biopharmaceutical company, develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates include AMI-101 for the treatment or prevention of Alzheimer's disease; and AMI-202 to treat and prevent amyotrophic lateral sclerosis. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. The company is based in Omaha, Nebraska.